98%
921
2 minutes
20
Hematopoietic stem and progenitor cells (HSPCs) and leukocytes circulate between the bone marrow (BM) and peripheral blood following circadian oscillations. Autonomic sympathetic noradrenergic signals have been shown to regulate HSPC and leukocyte trafficking, but the role of the cholinergic branch has remained unexplored. We have investigated the role of the cholinergic nervous system in the regulation of day/night traffic of HSPCs and leukocytes in mice. We show here that the autonomic cholinergic nervous system (including parasympathetic and sympathetic) dually regulates daily migration of HSPCs and leukocytes. At night, central parasympathetic cholinergic signals dampen sympathetic noradrenergic tone and decrease BM egress of HSPCs and leukocytes. However, during the daytime, derepressed sympathetic noradrenergic activity causes predominant BM egress of HSPCs and leukocytes via β-adrenergic receptor. This egress is locally supported by light-triggered sympathetic cholinergic activity, which inhibits BM vascular cell adhesion and homing. In summary, central (parasympathetic) and local (sympathetic) cholinergic signals regulate day/night oscillations of circulating HSPCs and leukocytes. This study shows how both branches of the autonomic nervous system cooperate to orchestrate daily traffic of HSPCs and leukocytes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449569 | PMC |
http://dx.doi.org/10.1182/blood-2018-08-867648 | DOI Listing |
J Biol Chem
August 2025
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, M5G 2C4, Canada; Department of Immunology, University of Toronto, Toronto, Ontario, M5G 2M9, Canada; Institute of Medical Science and Department of Pharmacology and Toxicology, University of Toronto, Toronto, O
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, of which atherosclerosis is the major pathology. Chronic inflammation underlies atherosclerosis, and Janus kinase 2 (Jak2) is a critical signaling node that mediates this process. Jak2 activating mutation has recently been implicated in clonal hematopoiesis of indeterminate potential as an emerging major CVD risk factor.
View Article and Find Full Text PDFCell Immunol
September 2025
Department of Clinical Hematology, College of Pharmacy and Laboratory Medicine Science, Army Medical University, 30# Gaotanyan Road, Shapingba District, Chongqing 400038, China; Thoracic Surgery Department, Southwest Hospital, The First Hospital Affiliated to Army Medical University, Chongqing, Chin
Human embryonic stem cell-derived NK (hESC-NK) cells or induced pluripotent stem cell derived NK cells have demonstrated efficacy and safety in clinical trials for cancer therapy and serve as a valuable tool for studying the mechanisms of human NK cell development and effector functions. We previously demonstrated that the methylase METTL3 was essential for the development and effector functions of murine NK cells, but its role in human NK cells remained unknown. Herein, we constructed an H1 ESC strain with reduced METTL3 expression using lentivirus-delivered short hairpin (sh) RNA and generated hESC-NK cells via a two-stage differentiation system.
View Article and Find Full Text PDFJ Ethnopharmacol
August 2025
School of Pharmacy, Naval Medical University, Shanghai, 200433, China. Electronic address:
Ethnopharmacological Relevance: Epimedium brevicornu Maxim., when used alone or as the principal component in traditional Chinese medicine (TCM) formulas, has the function of restoring internal "organs" and relieving fatigue. Shengbai Oral Liquid (SBOL), a TCM formula primarily composed of Epimedium brevicornu Maxim.
View Article and Find Full Text PDFAm J Physiol Endocrinol Metab
September 2025
Diabetes and Metabolic Disease, St. Vincent's Institute of Medical Research, Melbourne, Victoria, Australia.
Impaired cholesterol homeostasis is a major factor contributing to the development and progression of atherosclerosis. Previous studies have shown that metformin, the first-line antidiabetic therapy, has cardioprotective effects in patients with diabetes. However, the antiatherogenic effect of metformin in nondiabetic individuals remains unclear.
View Article and Find Full Text PDFJ Cell Mol Med
July 2025
Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Extramedullary haematopoiesis (EMH) refers to blood generation outside of the bone marrow (BM). In Myelofibrosis (MF), a myeloproliferative neoplasm, the disruption of BM microenvironment promotes haematopoietic stem and progenitor cells (HSPCs) mobilisation, resulting in the onset of EMH in the spleen, and then in splenomegaly. Although JAK2 inhibitors have a good efficacy in reducing splenomegaly, the presence of a significant proportion of non-responder patients underlines the need to explore the cellular mechanisms responsible for the EMH onset.
View Article and Find Full Text PDF